Independent global B2B platform
Expert in API & CDMO market
Direct contact between you and supplier

Find, compare & contact
Insulin Degludec API Manufacturers & Suppliers

Real trade data

Filters

Reset current filters

Type
Production region
Qualifications
Country of origin
Contact suppliers

HIGHLIGHTED

Located in:

China

Produced in:

China

Established in: 2017

MOQ: -

Employees: 200+

Manufacturing facility approved by FDA and GMP certified

Obtained CNAS laboratory accreditation certificate

Subsidiary of the US listed group Amphastar Pharmaceuticals

  • CoA

  • GMP

  • CEP

  • FDA

  • USDMF

  • + 0

All certificates

  • GMP

  • CoA

  • FDA

  • MSDS

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Insulin Degludec API 844439-96-9?

Description:
Here you will find a list of producers, manufacturers and distributors of Insulin Degludec. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Insulin Degludec 
Cas Number:
844439-96-9 
DrugBank number:
DB09564 
Unique Ingredient Identifier:
NN-1250;NN1250

About Insulin Degludec

Insulin Degludec, marketed under brand names like Tresiba, is an ultra-long-acting form of insulin, used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Unlike conventional insulin, it has an added hexadecanedioic acid on lysine at the B29 position, facilitating the formation of multi-hexamers upon subcutaneous injection. This unique structure allows for a protracted action profile, providing a consistent level of basal insulin over 42 hours with a low peak: trough ratio. Insulin Degludec's effectiveness in glycemic control makes it a vital component in diabetes management, particularly benefiting patients requiring stable and prolonged insulin action.

Insulin Degludec manufacturers | traders | suppliers

We have 1 companies offering Insulin Degludec produced in 1 different countries.

Get in contact with the supplier of your choice:

  • Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.